Hound Partners’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-49,830
Closed -$724K 226
2021
Q2
$724K Buy
+49,830
New +$724K 0.04% 194
2020
Q4
Sell
-57,200
Closed -$846K 139
2020
Q3
$846K Buy
+57,200
New +$846K 0.06% 89
2018
Q2
Sell
-42,082
Closed -$1.02M 27
2018
Q1
$1.02M Buy
+42,082
New +$1.02M 0.03% 21